The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of immune checkpoint inhibitors (ICI) in patients (pts) with central nervous system (CNS) metastases (mets) from solid tumors: A systematic review and meta-analysis.
 
Soraia Martins
Honoraria - Bristol Myers Squibb Foundation; Gilead Sciences; MSD Oncology; Novartis; Pierre Fabre; Roche
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Novartis; Roche
 
Diogo Martins-Branco
Employment - ESMO
Research Funding - F. Hoffmann LaRoche (Inst); Lilly (Inst); Novartis (Inst); Roche (Inst)
(OPTIONAL) Uncompensated Relationships - American Society of Clinical Oncology; Associação de Investigação e Cuidados de Suporte em Oncologia - Portuguese MASCC affiliate; Associação Portuguesa de Cuidados Paliativos; Multinational Association of Supportive Care in Cancer; Sociedade Portuguesa de Oncologia
 
Camila Lara Gismondi
No Relationships to Disclose
 
Marco Bruzzone
No Relationships to Disclose
 
Guilherme Nader Marta
Travel, Accommodations, Expenses - AstraZeneca
 
Tiago Pina Cabral
No Relationships to Disclose
 
Joana Gonçalves
Employment - National Heath Services
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - ESMO
 
Elisa Agostinetto
Honoraria - Abscint (Inst); AstraZeneca; Lilly
Consulting or Advisory Role - AstraZeneca (Inst)
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Abscint; AstraZeneca; AstraZeneca; Daiichi Sankyo Europe GmbH; Genetic Spa; Novartis
 
Marco Tagliamento
Consulting or Advisory Role - Oncotech
Travel, Accommodations, Expenses - Lilly
Other Relationship - Amgen; MSD; Novartis
 
Nuria Kotecki
Research Funding - BMS GmbH & Co. KG (Inst)
Travel, Accommodations, Expenses - Byondis; ose pharma; Pfizer
 
Matteo Lambertini
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Ipsen; Knight Therapeutics; Libbs; Lilly; Menarini; Novartis; Pfizer; Roche; Sandoz; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Roche
 
Eva Blondeaux
Honoraria - Lilly
Research Funding - Gilead Sciences
 
Matthias Preusser
Honoraria - Abbvie; Adastra Pharmaceuticals; AstraZeneca; Bayer; BMJ Journals; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Medahead; MedMedia; Merck Sharp & Dome; Mundipharma; Novartis; Roche; Sanofi; SERVIER; Telix Pharmaceuticals; Tocagen
Consulting or Advisory Role - AbbVie; Adastra Pharmaceuticals; AstraZeneca; Bayer; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo/Astra Zeneca; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Merck Sharp & Dome; Mundipharma; Novartis; Roche; Sanofi; SERVIER; Tocagen
Research Funding - AbbVie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme; Novartis (Inst); Roche (Inst); Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Mundipharma; Roche; SERVIER
 
Priscilla Brastianos
Consulting or Advisory Role - Advise Connect Inspire; Atavistik; Cranius; ElevateBio; InCephalo Therapeutics/University of Zurich; Kazia Therapeutics; Medscape; MPM Capital; Voyager Therapeutics
Research Funding - Kinnate Biopharma (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst)
 
Evandro de Azambuja
Honoraria - AstraZeneca; Gilead Sciences; Libbs (Inst); Lilly; MSD Oncology; Novartis/Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech; SeaGen; Zodiac Pharma
Consulting or Advisory Role - AstraZeneca (Inst); Libbs; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); GlaxoSmithKline/Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences
(OPTIONAL) Uncompensated Relationships - Belgian Society of Medical Oncology (BSMO); ESMO